$APOG

Apogee (APOG) Q2 2027 Earnings Call Transcript

Apogee (APOG) reported Q2 2027 earnings with net sales up 9.2% to $391.1M, driven by acquisitions and pricing. Adjusted EBITDA margin rose to 12.7%, and EPS increased 19% to $1.17. The company highlighted progress in metals, services, and glass segments, with services delivering 10 consecutive quarters of growth. Acquisitions of Kalwall and GrowGlass are expected to enhance capabilities and profitability. Management expressed confidence in long-term growth and shareholder value creation.

Original reporting
Published Oct 7, 2026, 2:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 3:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Apogee (APOG) Q2 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$APOGBullishHigh
01

Why it matters

The earnings beat and acquisition synergies suggest near‑term upside, but integration risk remains.

02

Market read

First‑time disclosure of Q2 earnings provides fresh data for traders to adjust positions in APOG and related industrial stocks.

03

What to watch

Potential slowdown in metals demand and higher material costs could temper future performance.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Apogee (APOG) held its Q2 2027 earnings call, outlining recent acquisitions and segment performance.

Company-level read

Ticker impact

$APOGBullishHigh confidence
Context

Apogee reported Q2 2027 results with net sales up 9.2% to $391.1M and adjusted EPS up 19% to $1.17, marking the first public disclosure of these figures.

Expected impact

likely upside as the market prices in the earnings beat and improved guidance

Evidence & confidence

Revenue and EPS both exceeded prior guidance, and the acquisition contributions were highlighted, supporting a bullish reaction.

Market effects

Materials and services segments may see broader investor interest due to demonstrated pricing power.

North American industrials could benefit from Apogee's growth narrative.

Positive earnings from a mid‑cap industrial player may lift related global supply‑chain stocks.

Counterpoint

If integration costs of Kalwall and GrowGlass exceed expectations, margins could be pressured despite top‑line growth.

Key entities

  • Apogee

    US‑listed industrial manufacturer reporting Q2 results.

  • Kalwall

    Recent acquisition contributing to revenue growth.

  • GrowGlass

    Second acquisition of the fiscal year, adding high‑value product capabilities.

Related articles

$APOGMedAI 8/10

Apogee Enterprises Inc (APOG) (Q2 2027) Earnings Call Highlights: Raised Guidance

Apogee Enterprises (APOG) reported Q2 2027 revenue of $391M, up 9% YoY, and adjusted EPS of $1.17, up 19%. The company raised its fiscal 2027 outlook due to strong first-half performance. Segment performance varied, with Services growing for the 10th consecutive quarter, while Glass and Performance Surfaces faced challenges. Acquisitions of Kalwall and Groglass are progressing well. Leverage ratio is 1.7 times, slightly above target. The company repurchased $6.4M of stock in Q2.

$APOGHighAI 8/10

Apogee raises fiscal 2027 guidance after second-quarter sales rise

Apogee Enterprises (APOG) reported a 9.2% sales increase to $391.1M in Q2, raising its fiscal 2027 adjusted EPS guidance to $3.00-$3.40 and net sales outlook to $1.46B-$1.50B. Operating income rose 24.5% to $33.5M, while net earnings fell 5.4% to $22.4M. Growth was driven by acquisitions, pricing, and product mix, though offset by lower volume and higher costs.

$APOGMed

Apogee Enterprises Q2 Earnings Call Highlights

Apogee Enterprises reported Q2 sales growth in all segments, with Architectural Metals up 1.8%, Services up 8%, Glass up 21%, and Performance Surfaces up 14%. Adjusted EBITDA margins varied, with Glass improving sequentially. The company expects Kalwall and Groglass acquisitions to boost revenue but have a modest EPS impact in 2027. Apogee repurchased $6.4M in stock and paid $5.5M in dividends, maintaining a leverage ratio of 1.7x.

$CEGHighAI 8/10

Market movers: Constellation Energy, Marvell, Lamb Weston, Option Care

Diodes (DIOD) received a buy rating and $135 target from BofA, expecting 58% annual EPS growth. Apogee (APOG) raised fiscal 2027 guidance after Q2 sales rose 9.2%. Marvell (MRVL) shares rose 6.5% on $70B-$90B 2031 revenue forecast. Lamb Weston (LW) increased 2027 targets despite net income drop. SAP (SAP) to acquire TechWolf; Mckesson (MCK) & CD&R to buy Option Care Health (OPCH) for $5.8B. Constellation Energy (CEG) in 20-year PPA with Alphabet (GOOG).

$APOGHighAI 8/10

Why Apogee (APOG) Stock Is Up Today

Apogee (APOG) shares rose 22.7% premarket after Q2 results beat estimates, with revenue of $391.1M (9.2% YoY growth) and adjusted EPS of $1.17 (84.3% beat). The company raised full-year EPS guidance to $3.00-$3.40. CEO Nolan attributed performance to pricing, productivity, and operational improvements. The stock is up 6.9% YTD but down 18.4% from its 52-week high.